WallStSmart
CHE

Chemed Corp

NYSE: CHE · HEALTHCARE · MEDICAL CARE FACILITIES

$424.98
+0.25% today

Updated 2026-04-30

Market cap
$5.69B
P/E ratio
23.14
P/S ratio
2.24x
EPS (TTM)
$18.32
Dividend yield
0.40%
52W range
$365 – $581
Volume
0.3M

WallStSmart proprietary scores

51
out of 100
Grade: C
Hold
Investment rating
4.0
Growth
C
7.0
Quality
B+
7.5
Profitability
B+
4.0
Valuation
C
3/9
Piotroski F-Score
Weak
5.8
Altman Z-Score
Safe zone
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$446.50
+5.06%
12-Month target
$373.47
-12.12%
Intrinsic (DCF)
$338.44
Margin of safety
-36.77%
0 Strong Buy1 Buy3 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Altman Z 5.81 — safe zone
+ ROE 25.60% — strong efficiency
+ Free cash flow $71.10M — positive
+ Debt/equity 0.13x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- 36.77% above intrinsic value

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$2.13B$2.26B$2.43B$2.53B$2.54B
Net income$249.62M$272.51M$302.00M$265.24M$66.30M
EPS$18.32
Free cash flow$252.56M$273.44M$367.97M$325.48M$71.10M
Profit margin11.69%12.03%12.42%10.48%10.20%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CHE$5.69B514.07.54.07.0-36.77%Buy
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Chemed Corp trades at $424.98. representing a P/E of 23.14x trailing earnings. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 5.81, it sits in the safe zone. TTM revenue stands at $2.54B. with profit margins at 10.20%. Our DCF model estimates intrinsic value at $338.44.

Frequently asked questions

What is Chemed Corp's stock price?
Chemed Corp (CHE) trades at $424.98.
Is Chemed Corp overvalued?
Smart Value Score 51/100 (Grade C, Hold). DCF value $338.44.
What is the price target of Chemed Corp (CHE)?
The analyst target price is $446.50, representing +5.1% upside from the current price of $424.98.
What is the intrinsic value of Chemed Corp (CHE)?
Based on our DCF model, intrinsic value is $338.44, a -36.8% margin of safety versus $424.98.
What is Chemed Corp's revenue?
TTM revenue is $2.54B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
5.81 — safe zone.

Company info

SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD

Quick metrics

P/S ratio2.24x
ROE25.60%
Beta0.48
50D MA$402.92
200D MA$433.07
Shares out0.01B
Float0.01B
Short ratio
Avg volume0.3M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years